SS Innovations International (SSII) EBITDA Margin (2022 - 2026)
SS Innovations International's (SSII) quarterly EBITDA Margin came in at 13.81% in Q2 2026, down 1738.0% year-over-year from 0.84% in Q2 2025, and up 53.75% quarter-over-quarter from 29.86% in Q1 2026.
Powered by 
Analysis
SS Innovations International (SSII) EBITDA Margin (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed EBITDA Margin across 5 years of filings, most recently posting 13.81% for Q2 2026.
- In Q2 2026, EBITDA Margin fell 1738.0% year-over-year to 13.81%; the TTM figure through Jun 2026 stood at 13.75% (up 2294.0% YoY), while the FY2025 annual figure was 16.75%, up 7303.0% from the prior year.
- EBITDA Margin came in at 13.81% for Q2 2026 at SS Innovations International, up from 29.86% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 3.57% in Q2 2025 to a low of 546.98% in Q4 2023.
- Average EBITDA Margin over 5 years is 122.99%, with a median of 79.31% recorded in 2022.
- Year-over-year, EBITDA Margin slumped 45253 bps in 2023 and surged 52613 bps in 2024.
- Over 5 years, EBITDA Margin stood at 94.45% in 2022, then plunged by 479 bps to 546.98% in 2023, then surged by 96 bps to 20.86% in 2024, then surged by 86 bps to 2.93% in 2025, then slumped by 372 bps to 13.81% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 13.81% in Q2 2026, 29.86% in Q1 2026, and 2.93% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | SS Innovations International | 650.44 Mn | 628.15 Mn | 7.10 Mn | -13.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.81% |
| Mar 31, 2026 | -29.86% |
| Dec 31, 2025 | -2.93% |
| Sep 30, 2025 | -11.99% |
| Jun 30, 2025 | 3.57% |
| Mar 31, 2025 | -111.57% |
| Dec 31, 2024 | -20.86% |
| Sep 30, 2024 | -70.34% |
| Jun 30, 2024 | -88.92% |
| Mar 31, 2024 | -268.09% |
| Dec 31, 2023 | -546.98% |
| Sep 30, 2023 | -82.92% |
| Jun 30, 2023 | -272.58% |
| Mar 31, 2023 | -280.46% |
| Dec 31, 2022 | -94.45% |
| Sep 30, 2022 | -75.69% |